List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 427 studies with search of:   Canada, Newfoundland and Labrador
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Completed A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes
Interventions: Drug: dapagliflozin;   Drug: dapagliflozin;   Drug: dapagliflozin;   Drug: dapagliflozin;   Drug: dapagliflozin;   Drug: placebo;   Drug: metformin
22 Recruiting Open Label Study Telmisartan and Amlodipine in Hypertension
Condition: Hypertension
Interventions: Drug: telmisartan/amlodipine 40/5 mg fixed combination;   Drug: telmisartan/amlodipine 80/5 mg fixed combination
23 Completed Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
Condition: Arrhythmia
Interventions: Drug: Azimilide Dihydrochloride;   Drug: placebo;   Drug: Azimilide Dihydrochloride
24 Completed Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension
Condition: Hypertension
Interventions: Drug: Telmisartan;   Drug: Ramipril
25 Active, not recruiting Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: bezafibrate + diflunisal;   Drug: bezafibrate + placebo
26 Completed PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
Condition: Hypertension
Interventions: Drug: Telmisartan;   Drug: Ramipril
27 Active, not recruiting A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin
Conditions: Non-Insulin-Dependent Diabetes Mellitus;   Type 2 Diabetes Mellitus
Intervention: Drug: Rosiglitazone maleate/metformin hydrochloride (AVANDAMET)
28 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
29 Completed Chest Pain Pilot Study
Conditions: Chest Pain;   Gastroesophageal Reflux
Intervention: Drug: Esomeprazole
30 Recruiting Assessment and Tracking of Long-Term Alefacept Safety
Condition: Psoriasis
Intervention: Drug: Alefacept exposure
31 Not yet recruiting The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
Conditions: Atherosclerosis;   Cardiovascular Disease;   Coronary Heart Disease;   CV Risk
Interventions: Drug: Darapladib;   Drug: Placebo
32 Completed Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Quetiapine;   Drug: Amitriptyline;   Drug: Bupropion;   Drug: Citalopram;   Drug: Duloxetine;   Drug: Escitalopram;   Drug: Fluoxetine;   Drug: Paroxetine;   Drug: Sertraline;   Drug: Venlafaxine
33 Active, not recruiting Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine
Condition: Hepatitis B
Interventions: Biological: 1018 ISS immunostimulatory oligonucleotide with HBV surface antigen;   Biological: Hepatitis B Vaccine (Recombinant)
34 Recruiting Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease
Condition: Cystic Fibrosis
Interventions: Drug: Denufosol Tetrasodium (INS37217) Inhalation Solution;   Drug: Placebo
35 Completed A 36-Week Extension to Protocol ISA04-03
Condition: Psoriasis
Intervention: Drug: voclosporin
36 Completed Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
Conditions: NSAIDs;   Upper GI Symptoms
Intervention: Drug: Esomeprazole
37 Completed Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: muraglitazar
38 Recruiting Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin
Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin;   Drug: Placebo
39 Active, not recruiting Tretinoin, Cytarabine, and Daunorubicin With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
Condition: Leukemia
Interventions: Drug: arsenic trioxide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: tretinoin
40 Completed SMOOTH - Blood Pressure Control in Diabetic/Obese Patients
Conditions: Hypertension;   Diabetes Mellitus, Type 2
Interventions: Drug: telmisartan combined with hydrochlorothiazide (80/12.5 mg);   Drug: valsartan combined with hydrochlorothiazide (160/12.5mg)

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services